Lenz Robert A. 4
4 · Neumora Therapeutics, Inc. · Filed Sep 18, 2023
Insider Transaction Report
Form 4
Lenz Robert A.
Head of R&D
Transactions
- Award
Stock Option (Right to Buy)
2023-09-14+502,934→ 502,934 totalExercise: $17.00Exp: 2033-09-13→ Common Stock (502,934 underlying) - Award
Common Stock
2023-09-14+352,941→ 352,941 total
Footnotes (2)
- [F1]Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/4th of the RSUs vest annually on September 11 of each year, with the first 1/4th vesting on September 11, 2024.
- [F2]25% of the shares subject to the option vest on the first anniversary measured from September 11, 2023 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.